Immunosuppressive Agents: all 5,940 studies that test it
Page 35 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast CancerCompletedNCT03017404Not applicable
- Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) StudyStatus unknownNCT03016715Phase 2
- Thalidomide Maintenance Treatment in DLBCLStatus unknownNCT03016000Phase 3
- Fosbretabulin With Everolimus in Neuroendocrine Tumors With ProgressionTerminatedNCT03014297Phase 1
- Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin LymphomaCompletedNCT03013933Phase 1
- A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial CarcinomaActive, not recruitingNCT03008408Phase 2
- Basiliximab vs Low-dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant PatientsCompletedNCT03006419Phase 4
- AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney TransplantationStatus unknownNCT03005236Phase 4
- 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance TherapyActive, not recruitingNCT03004287Phase 2
- Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type PsoriasisStatus unknownNCT02999776Phase 1
- Thalidomide Results in Diminished Ovarian Reserve in Reproductive Age Female IBD PatientsStatus unknownNCT02998827Not applicable
- Haploidentical BMT With Post-Transplant Cyclophosphamide and BendamustineCompletedNCT02996773Phase 1
- The Effective and Safety of Thalidomide in NTDTStatus unknownNCT02995707Phase 2
- Impact of Sirolimus and Maraviroc on CCR5 Expression and the HIV-1 Reservoir in HIV-infected Kidney Transplant RecipientsWithdrawnNCT02990312Phase 4
- NATIENS: Optimal Management and Mechanisms of SJS/TENCompletedNCT02987257Phase 3
- Bevacizumabe or Triamcinolone for Persistent Diabetic Macular EdemaCompletedNCT02985619Phase 2/3
- Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple MyelomaWithdrawnNCT02985333Phase 2
- Takayasu Arteritis Clinical Trial in ChinaCompletedNCT02981979Not applicable
- Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast CancerCompletedNCT02980965Phase 3
- PCD Versus RCD for the Treatment of Patients With Waldenstrom's MacroglobulinemiaStatus unknownNCT02971982Phase 1/2
- Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical StudyCompletedNCT02970630Phase 2
- Hematopoietic Cell Transplantation With Post-transplantation Cyclophosphamide in MDSCompletedNCT02969980Phase 2
- TB Host Directed TherapyStatus unknownNCT02968927Phase 2
- Thalidomide/Dexamethasone Treatment And PET Evaluation In Organ Involvemenet of Cardiac AmyloidosisStatus unknownNCT02966522Phase 2
- The p53 Breast Cancer TrialActive, not recruitingNCT02965950Phase 2
- A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive RegimenTerminatedNCT02963103Phase 4
- Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued TreatmentActive, not recruitingNCT02962414Phase 3
- Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02960646Phase 1
- A Study of the MASEI in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With SpondyloarthritisCompletedNCT02960035Phase 4
- Dimethyl Fumarate Treatment of Primary Progressive Multiple SclerosisCompletedNCT02959658Phase 2
- Induced Adult Refractory Active Crohn's Disease Clinical Relieving by Using ThalidomideStatus unknownNCT02956538Early Phase 1
- Combinating Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic StrokeWithdrawnNCT02956200Phase 2
- Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA)Status unknownNCT02955810Phase 1
- Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008CompletedNCT02955693Phase 1
- PD 0360324 and Cyclophosphamide in Treating Patients With Recurrent High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerWithdrawnNCT02948101Phase 2
- BE Study in Patients - Methotrexate TabletsStatus unknownNCT02940561Phase 1
- Precision Medicine Offers Belatacept MonotherapyWithdrawnNCT02939365Phase 4
- Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma MultiformeStatus unknownNCT02937844Phase 1
- Efficacy of Idarubicin, Cytarabine and Cyclophosphamide (IAC) Regimen in Relapsed/Refractory AMLCompletedNCT02937662Phase 2
- Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.Active, not recruitingNCT02936505Not applicable
- CD19-redirected Autologous Cells (CAR-CD19 T Cells)Status unknownNCT02933775Phase 1
- Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)Active, not recruitingNCT02932956Phase 1
- Triamcinolone Injections for Persistent Choroidal Effusions Post Glaucoma SurgeryStatus unknownNCT02917564Phase 4
- Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up StudyCompletedNCT02915354Phase 4
- Mercaptopurine Therapy in Ulcerative ColitisStatus unknownNCT02910245Phase 3
- De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised StudyWithdrawnNCT02909335Phase 3
- Cyclosporine A Pretreatment and Kidney Graft FunctionCompletedNCT02907554Phase 4
- Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)CompletedNCT02905188Phase 1
- Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children with Recurrent Posterior Fossa Brain TumorsCompletedNCT02905110Early Phase 1
- Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast CancerStatus unknownNCT02903524Phase 4
- Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP)CompletedNCT02902861Phase 3
- Nivolumab in Relapsed Pediatric Solid TumorsStatus unknownNCT02901145Phase 1/2
- Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarateTerminatedNCT02901106Phase 4
- Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast CancerSuspendedNCT02897050Phase 2
- 2-week dc of MTX and Influenza Vaccination in RAStatus unknownNCT02897011Not applicable
- Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic DermatitisCompletedNCT02896101Phase 3
- Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance StrategyCompletedNCT02891811Phase 2
- Influence of CYP3A5 Polymorphism on Liver Function Abnormality and the Trough Level Change After ConversionStatus unknownNCT02882113Phase 4
- Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified TreatmentCompletedNCT02881086Phase 3
- Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"Status unknownNCT02878161Phase 4
- Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell CarcinomaStatus unknownNCT02876978Phase 1
- Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCTCompletedNCT02876679Phase 2
- Postconditioning by Cyclosporin A in Pulmonary TransplantationWithdrawnNCT02876250Phase 3
- Adjunctive Steroid Combination in Ocular Trauma (ASCOT) StudyCompletedNCT02873026Phase 3
- Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)Active, not recruitingNCT02870907Phase 2
- Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell DiseaseCompletedNCT02867800Phase 1
- A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT02867306Phase 1
- Topical Solution for the Treatment of Atopic DermatitisCompletedNCT02865356Phase 2
- Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantActive, not recruitingNCT02861417Phase 2
- Topical Everolimus in Patients With Tuberous Sclerosis ComplexWithdrawnNCT02860494Phase 2/3
- EDOCH Alternating With DHAP for New Diagnosed Younger MCLCompletedNCT02858804Phase 4
- Reduce Risk for Crohn's Disease PatientsCompletedNCT02852694Phase 4
- LBL-2016 for Children or Adolescents in ChinaActive, not recruitingNCT02845882Phase 3
- Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic AnemiaCompletedNCT02845596Not applicable
- The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WMCompletedNCT02844309Phase 4
- Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma MultiformeStatus unknownNCT02844062Phase 1
- Thermography in Assessing Treatment Response to Golimumab in Psoriatic ArthritisTerminatedNCT02841176Not applicable
- Treatment Tapering in JIA With Inactive DiseaseCompletedNCT02840175Phase 3
- ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic AnemiaStatus unknownNCT02838992Phase 4
- Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine TumorsCompletedNCT02838342Phase 2
- The Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months and Long-term TreatmentCompletedNCT02837978Phase 4
- Ultrasound as Imaging Biomarker of Early Response to Tocilizumab and Methotrexate in Very Early Rheumatoid ArthritisStatus unknownNCT02837146Phase 3
- Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWithdrawnNCT02833506Phase 1
- Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe PsoriasisTerminatedNCT02829424Phase 4
- Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell LymphomaCompletedNCT02825147Phase 2
- Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and ChondrosarcomaCompletedNCT02821507Phase 2
- Omental Islet TransplantCompletedNCT02821026Phase 1/2
- Single-centre Study of Everolimus as GvHD Prophylaxis After Post-Transplantation Cyclophosphamide After Allogeneic SCTCompletedNCT02812940Phase 2
- Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal VasculopathyStatus unknownNCT02806752Phase 4
- PTCy and Ruxolitinib GVHD Prophylaxis in MyelofibrosisCompletedNCT02806375Phase 1/2
- Incidence of Non Adherence to Treatment With Once-daily Formulation of TacrolimusStatus unknownNCT02805842Phase 3
- Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered SubcutaneouslyStatus unknownNCT02805010Phase 1
- Monotherapy With Rapamycin in Long-standing Type 1 DiabetesCompletedNCT02803892Phase 2
- Ocular Penetration of Topical Tacrolimus Eye DropsStatus unknownNCT02794610Not applicable
- Cyclophosphamide for Nasopharyngeal CarcinomaCompletedNCT02794077Phase 2
- Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and OverStatus unknownNCT02792491Phase 2
- Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Patients With Common Variable ImmunodeficiencyWithdrawnNCT02789397Phase 2
- Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian CancerActive, not recruitingNCT02785250Phase 1/2
- Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell TumorStatus unknownNCT02784054Phase 2
- Response Based Treatment for Children With Unresectable Localized Soft Tissue SarcomaStatus unknownNCT02784015Phase 2